Getting Under Canine Pyoderma's Skin

Total Page:16

File Type:pdf, Size:1020Kb

Getting Under Canine Pyoderma's Skin Vet Times The website for the veterinary profession https://www.vettimes.co.uk Getting under canine pyoderma’s skin Author : DAVID H SHEARER Categories : Vets Date : June 23, 2008 DAVID H SHEARER explains various procedures that can help to treat this common but persistent problem CANINE bacterial pyoderma is a common problem in small animal practice, most often caused by the facultative pathogen Staphylococcus intermedius. It is often secondary to some other concurrent and underlying skin disease that leads to microclimate changes that are either locally, or more generally, favourable to colonisation and infection by Staphylococci. Although an underlying disease may be identified, some dogs appear to have an idiopathic recurrent pyoderma that entirely responds to antibacterial therapy, but recurs at a variable time after cessation of treatment. Dermatologists do not agree on the exact pathogenesis of these idiopathic pyoderma cases. Aetiology It is generally accepted that S intermedius is resident on the surface of the mucous membranes (nares, oropharynx and anal ring) and the associated cutaneous margins and is, therefore, considered to be a facultative pathogen. Under some circumstances, the organism spreads from carriage sites to other areas, where it colonises the skin and adnexae. To do this, the organism must be able to adhere to corneocytes and then proliferate at these sites. The proliferation of the organism leads to the production of a 1 / 16 variety of extracellular and intracellular antigens. The extracellular antigens are produced by the living bacteria and may be involved in adhesion to keratinocytes and protection from the host immune system. These include toxins and enzymes, some of which can act as superantigens. They are cell components that are released when the bacteria die. The cellular antigens are known to produce a humoral immune response involving immunoglobulin G, but whether this is a protective response is not known. Super ant I gens can produce an inappropriate or aberrant immune response, and may be involved in the promotion of allergy or the development of autoimmune skin disease. In this way, recurrent pyoderma in an atopic dog may act as a significant promoter of the allergic response in the skin immune system. It has also been proposed that chronic exposure to Staphylococci antigens may promote the development of autoimmune skin disease, but this remains unproven. For these reasons alone, it is vital to treat or control any recurrent pyoderma in dogs. It is important to note that a staphylococcal pyoderma is considered to be a flare factor in atopic dogs, but there is suspicion that it may promote allergy and even contribute to the development of autoimmune disease. Clinical classification Pyoderma is usually clinically classified as surface, superficial and deep. However, it can also be classified as a localised (see Table 1) or generalised disease. • Surface pyoderma The most common example of a surface pyoderma is acute moist dermatitis, which is an ulcerative inflammatory process caused by trauma, typically following a flea bite. Acute moist dermatitis is a common superficial form of pyotraumatic dermatitis. The other form is a folliculitis, which is a deeper process. Intertrigo is a surface pyoderma occurring as the result of friction. • Superficial pyoderma Superficial pyodermas are defined as those affecting the infundibular portion of the hair follicle. - Impetigo Impetigo is a superficial pyoderma seen in young dogs and presents as a non-pruritic, non- follicular, pustular disease with collarettes, especially on the non-haired axillary and inguinal skin. Cases may spontaneously resolve, but should respond to topical antibacterial shampooing. 2 / 16 - Cutaneous bacterial overgrowth This is a syndrome that is presented as a pruritic dermatitis that responds completely to antibacterial therapy. It is characterised by the presence of large numbers of bacteria on examination of acetate strip preparations that are not necessarily within phagocytes. - Mucocutaneous pyoderma This is a relatively common localised pyoderma that affects mucous membranes and/or cutaneous junctions, such as the lips and nares. The main differential diagnoses for these lesions is cutaneous lupus (discoid lupus). However, diagnosis can prove difficult because the histological features are indistinguishable from one to the other (Wiemelt et al, 2004). Topical antibacterial therapy and systemic antibiotics should resolve mucocutaneous pyoderma, but recurrence will occur if predisposing factors remain (such as nasal discharges). - Bacterial folliculitis This is probably the most common manifestation of canine pyoderma. The lesions seen are papules, pustules, collarettes and alopecia. Underlying allergies, ectoparasitic or endocrine diseases should always be considered and appropriate diagnostic tests performed. - Superficial spreading pyoderma This is another form of superficial pyoderma, characterised by large collarettes with an erythematous expanding margin, most often affecting the trunk. These cases lack pustules. • Deep pyoderma A deep pyoderma is one that affects the entire hair follicle and is usually identified histologically as a furunculosis. Deep pyoderma is most often seen in interdigital pyogranulomas, lick granulomas and chin acne. An uncommon form of deep pyoderma is idiopathic German shepherd dog deep pyoderma, which produces ulcers and sinus tracts on the trunk, ventrum and thighs (Figure 1). This is most likely a multifactorial disease leading to deep bacteria pyoderma, but the exact aetiopathogenesis remains unproven. Working up cases 3 / 16 As with all dermatology cases, a thorough history is essential and, apart from a detailed examination of the skin, a general physical examination should be performed, and the lesions carefully documented. The type of lesions and their distribution will often indicate the likely type of pyoderma present and the differential diagnoses (see Table 2 for signs associated with pyoderma). • Diagnostic techniques - Cytology Because of the thin nature of the stratum corneum in the dog, compared to species such as humans, pustules rapidly rupture and form crusts. Hence, we rarely find intact pustules to sample in most cases of bacterial pyoderma in the dog. Cytological examination of impression smears of pustule contents (if you manage to find any) and the contents of sinus tracts or nodules and acetate strip preparations (as used to detect yeasts) are useful in the evaluation of the various forms of canine pyoderma. If you easily find numerous coccoid bacteria on microscopic examination in these samples, whether on squames or within neutrophils, then they should be considered potentially significant and appropriate antibacterial therapy prescribed. For most cases of canine pyoderma, cytological examination of pustules or acetate strips from the lesion surface should be part of the initial diagnostic investigation. - Biopsy Tissue biopsies may be collected for both histopathology and microbiology. Both techniques have their place in the investigation of pyoderma. In particular, deep pyodermas producing nodules and sinus tracts are best investigated using both cytology of sinus contents and biopsy for histopathology and microbiology. Histopathology can be used in an attempt to rule out neoplasia and identify the important differential diagnoses of dermatophytosis and demodicosis. Treatment Cases of canine pyoderma are treated by identifying and treating a concurrent or underlying cause (see Table 3), systemic antibiotics and topical antibacterial agents. The most important underlying diseases to consider in all cases of pyoderma are those formed from allergies and parasites. This is especially true in cases presenting with pruritus as a major sign, and where pruritus remains after antibacterial therapy has resolved crusts, scales and alopecia. Parasites and allergies should always be considered high on the list of differential diagnoses in 4 / 16 cases of pyoderma with pruritus (Table 4). • Antibiotics used in treatment of canine pyoderma There are numerous antibiotics available for the treatment of canine pyoderma and the reader should always check the data sheet for directions carefully. See Table 5 for the possible causes of antibacterial treatment failure. The antibiotics suggested for pyoderma at first presentation (first-line) are trimethoprimsulphonamide (15mg/kg q12hr to 30mg/kg q12hr), erythromycin (15mg/kg q8hr), lincomycin (20mg/kg q12hr to 30mg/kg q12hr) and clindamycin (5mg/kg q12hr to 10mg/kg q12hr). Antibiotics suggested for recurrent or deep pyodermas (second-line) are cephalosporins (for example, cephalexin 20mg/ kg q12hr to 30mg/kg q12hr), amoxicillin and clavulanic acid (20mg/kg q12hr to 25mg/ kg q12hr) or fluoroquinolones (enrofloxacin at 5mg/kg q24hr to 10mg/kg q24hr and marbofloxacin 2mg/kg q24hr to 5mg/kg q24hr). • Topical antibacterial preparations A number of shampoos are available for the treatment of pyoderma. The instructions on the bottles should be followed carefully, but treatment two to three times weekly is usually advised initially. In all cases of bacterial folliculitis, both systemic and topical antibacterial therapy should be used and continued for several weeks after clinical cure. Bacterial autogenous vaccines (bacterins) made from a sample of the patient’s own staphylococci have been used to treat recurrent bacterial pyoderma. The mechanism of action is not known. However, it is suspected to be via stimulation of a cell mediated
Recommended publications
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Skin and Soft Tissue Infections Ohsuerin Bonura, MD, MCR Oregon Health & Science University Objectives
    Difficult Skin and Soft tissue Infections OHSUErin Bonura, MD, MCR Oregon Health & Science University Objectives • Compare and contrast the epidemiology and clinical presentation of common skin and soft tissue diseases • State the management for skin and soft tissue infections OHSU• Differentiate true infection from infectious disease mimics of the skin Casey Casey is a 2 year old boy who presents with this rash. What is the best treatment? A. Soap and Water B. Ibuprofen, it will self OHSUresolve C. Dicloxacillin D. Mupirocin OHSUImpetigo Impetigo Epidemiology and Treatment OHSU Ellen Ellen is a 54 year old morbidly obese woman with DM, HTN and venous stasis who presented with a painful left leg and fever. She has had 3 episodes in the last 6 months. What do you recommend? A. Cefazolin followed by oral amoxicillin prophylaxis B. Vancomycin – this is likely OHSUMRSA C. Amoxicillin – this is likely erysipelas D. Clindamycin to cover staph and strep cellulitis Impetigo OHSUErysipelas Erysipelas Risk: lymphedema, stasis, obesity, paresis, DM, ETOH OHSURecurrence rate: 30% in 3 yrs Treatment: Penicillin Impetigo Erysipelas OHSUCellulitis Cellulitis • DEEPER than erysipelas • Microbiology: – 6-48hrs post op: think GAS… too early for staph (days in the making)! – Periorbital – Staph, Strep pneumoniae, GAS OHSU– Post Varicella - GAS – Skin popping – Staph + almost anything! Framework for Skin and Soft Tissue Infections (SSTIs) NONPurulent Purulent Necrotizing/Cellulitis/Erysipelas Furuncle/Carbuncle/Abscess Severe Moderate Mild Severe Moderate Mild I&D I&D I&D I&D IV Rx Oral Rx C&S C&S C&S C&S Vanc + Pip-tazo OHSUEmpiric IV Empiric MRSA Oral MRSA TMP/SMX Doxy What Are Your “Go-To” Oral Options For Non-Purulent SSTI? Amoxicillin Doxycycline OHSUCephalexin Doxycycline Trimethoprim-Sulfamethoxazole OHSU Miller LG, et al.
    [Show full text]
  • Antibiotic Use Guidelines for Companion Animal Practice (2Nd Edition) Iii
    ii Antibiotic Use Guidelines for Companion Animal Practice (2nd edition) iii Antibiotic Use Guidelines for Companion Animal Practice, 2nd edition Publisher: Companion Animal Group, Danish Veterinary Association, Peter Bangs Vej 30, 2000 Frederiksberg Authors of the guidelines: Lisbeth Rem Jessen (University of Copenhagen) Peter Damborg (University of Copenhagen) Anette Spohr (Evidensia Faxe Animal Hospital) Sandra Goericke-Pesch (University of Veterinary Medicine, Hannover) Rebecca Langhorn (University of Copenhagen) Geoffrey Houser (University of Copenhagen) Jakob Willesen (University of Copenhagen) Mette Schjærff (University of Copenhagen) Thomas Eriksen (University of Copenhagen) Tina Møller Sørensen (University of Copenhagen) Vibeke Frøkjær Jensen (DTU-VET) Flemming Obling (Greve) Luca Guardabassi (University of Copenhagen) Reproduction of extracts from these guidelines is only permitted in accordance with the agreement between the Ministry of Education and Copy-Dan. Danish copyright law restricts all other use without written permission of the publisher. Exception is granted for short excerpts for review purposes. iv Foreword The first edition of the Antibiotic Use Guidelines for Companion Animal Practice was published in autumn of 2012. The aim of the guidelines was to prevent increased antibiotic resistance. A questionnaire circulated to Danish veterinarians in 2015 (Jessen et al., DVT 10, 2016) indicated that the guidelines were well received, and particularly that active users had followed the recommendations. Despite a positive reception and the results of this survey, the actual quantity of antibiotics used is probably a better indicator of the effect of the first guidelines. Chapter two of these updated guidelines therefore details the pattern of developments in antibiotic use, as reported in DANMAP 2016 (www.danmap.org).
    [Show full text]
  • Pyoderma Gangrenosum in Myelodysplasia and Acute Leukaemia
    Postgrad Med J: first published as 10.1136/pgmj.61.718.689 on 1 August 1985. Downloaded from Postgraduate Medical Journal (1985) 61, 689-694 Pyoderma gangrenosum in myelodysplasia and acute leukaemia Peter Jacobs', S. Palmer2 and E.C. Gordon-Smith2 'The University ofCape Town Leukaemia Centre and the Department ofHaematology, Groote Schuur Hospital, Observatory, 7925, Cape Town, South Africa and 'The Department ofHaematology, Royal Postgraduate Medical School, London, UK. Summary: Pyoderma gangrenosum is a rare occurrence in patients with haematological malignancy. This characteristic but nonspecific inflammatory process with skin destruction occurred in 4 patients with myelodysplasia, in one with acute leukaemic transformation of myelofibrosis, and in de novo acute myeloblastic leukaemia in another. Clinically, the cutaneous lesion in these patients differed from that associated with inflammatory bowel disease, arthritis, or the idiopathic type ofpyoderma gangrenosum by having the vesiculo-bulious borders. Histopathological differences were also evident since more superficial layers ofthe skin were involved in the ulceration than typically encountered in patients with non-malignant systemic disease. Despite the less penetrating nature of this variant, treatment of the pyoderma gangrenosum is unsatisfactory and in the absence of effective therapy for the underlying disease, healing occurred only in the patient with acute leukaemia who achieved complete remission in response to chemotherapy. copyright. Introduction Pyoderma gangrenosum
    [Show full text]
  • Module Test № 1 on Dermatology
    THE MINISTRY OF HEALTHCARE OF THE RUSSIAN FEDERATION FEDERAL STATE BUDGETARY EDUCATIONAL INSTITUTION OF HIGHER PROFESSIONAL EDUCATION PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY DEPARTMENT OF DERMATOVENEROLOGY Gaydina T.A., Dvornikov A.S., Skripkina P.A., Nazhmutdinova D.K., Heydar S.A., Arutunyan G.B., Pashinyan A.G. MODULE TEST №1 ON DERMATOLOGY FOR STUDENTS OF INSTITUTES OF HIGHER MEDICAL EDUCATION ON SPECIALTY THERAPEUTIC FACULTY DEPARTMENT OF DERMATOVENEROLOGY Moscow 2016 ISBN УДК ББК A21 Module test №1 on Dermatology for students of institutes of high medical education on specialty «Therapeutic faculty» department of dermatovenerology: manual for students for self-training//FSBEI HPE “Pirogov RNRMU” of the ministry of healthcare of the russian federation, M.: (publisher) 2016, 144 p. The manual is a part of teaching-methods on Dermatovenerology. It contains tests on Dermatology on the topics of practical sessions requiring single or multiple choice anser. The manual can be used to develop skills of students during practical sessions. It also can be used in the electronic version at testing for knowledge. The manual is compiled according to FSES on specialty “therapeutic faculty”, working programs on dermatovenerology. The manual is intended for foreign students of 3-4 courses on specialty “therapeutic faculty” and physicians for professional retraining. Authors: Gaydina T.A. – candidate of medical science, assistant of dermatovenerology department of therapeutic faculty Pirogov RNRMU Dvornikov A.S. – M.D., professor of dermatovenerology department of therapeutic faculty Pirogov RNRMU Skripkina P.A. – candidate of medical science, assistant professor of dermatovenerology department of therapeutic faculty Pirogov RNRMU Nazhmutdinova D.K. – candidate of medical science, assistant professor of dermatovenerology department of therapeutic faculty Pirogov RNRMU Heydar S.A.
    [Show full text]
  • Superficial Pyoderma
    W2825-Ch003.qxd 8/4/2005 13:33 Page 34 34 CHAPTER 3 Bacterial Skin Diseases Superficial Pyoderma (superficial bacterial folliculitis) Features emerging as a common canine isolate in patients with Superficial pyoderma is a superficial bacterial infection chronic infections and previous antibiotic exposure. Ad- involving hair follicles and the adjacent epidermis. The ditionally, methicillin-resistant Staphylococcus aureus infection usually occurs secondary to an underlying (human MRSA) may be becoming more common cause; allergies and endocrine disease are the most among veterinary species. common causes (Box 3-3). Superficial pyoderma is common in dogs and rare in cats. Superficial pyoderma is characterized by focal, mul- Top Differentials tifocal, or generalized areas of papules, pustules, Differentials include demodicosis, dermatophytosis, crusts, and scales, epidermal collarettes, or circum- scabies, and autoimmume skin diseases. scribed areas of erythema and alopecia that may have hyperpigmented centers. Short-coated dogs often present with a “moth-eaten” patchy alopecia, small Diagnosis tufts of hair that stand up, or reddish brown discol- 1. Rule out other differentials oration of white hairs. In long-coated dogs, symptoms 2. Cytology (pustule): neutrophils and bacterial cocci can be insidious and may include a dull, lusterless hair 3. Dermatohistopathology: epidermal microabscesses, coat, scales, and excessive shedding. In both short- and nonspecific superficial dermatitis, perifolliculitis, long-coated breeds, primary skin lesions are often and folliculitis. Intralesional bacteria may be diffi- obscured by remaining hairs but can be readily appre- cult to find ciated if an affected area is clipped. Pruritus is variable, 4. Bacterial culture: Staphylococcus species ranging from none to intense levels.
    [Show full text]
  • Z:\My Documents\WPDOCS\IACUC
    ZOONOTIC DISEASES OF LABORATORY, AGRICULTURAL, AND WILDLIFE ANIMALS July, 2007 Michael S. Rand, DVM, DACLAM University Animal Care University of Arizona PO Box 245092 Tucson, AZ 85724-5092 (520) 626-6705 E-mail: [email protected] http://www.ahsc.arizona.edu/uac Table of Contents Introduction ............................................................................................................................................. 3 Amebiasis ............................................................................................................................................... 5 B Virus .................................................................................................................................................... 6 Balantidiasis ........................................................................................................................................ 6 Brucellosis ........................................................................................................................................ 6 Campylobacteriosis ................................................................................................................................ 7 Capnocytophagosis ............................................................................................................................ 8 Cat Scratch Disease ............................................................................................................................... 9 Chlamydiosis .....................................................................................................................................
    [Show full text]
  • Abstracts 501-750
    150 salivary glands was greatly reduced by ron2 silencing, despite sporogony, and accompanying upregulation of PfRad51, PfRad54, PfRPA1L and sporozoite release into hemocoel and their motility were normal. These PfRPA1S at the level of transcript and protein. This study provides new results showed that RON2 is required for salivary gland invasion. This is the insights into the role of putative Rad51-interacting proteins involved in first genetical approach to show that RON2 has an important role in target homologous recombination and emphasizes physiological role of DNA cell invasion. damage repair during the growth of parasites. We are now characterizing the recombiantion macromolecular complex which is likely to be important 499 in DNA damage and repair and validating molecular interactions between PfRad51 and its putative interacting partners. Besides understanding IDENTIFICATION AND CHARACTERIZATION OF A molecular machinery involved in DNA repair and recombination, we wish PLASMODIUM FALCIPARUM ORTHOLOGUE OF THE YEAST to extend our studies to understand the biochemical and genetic basis of UBIQUINONE-BINDING PROTEIN, COQ10P gene rearrangements at the var gene locus associated with phenomenon like antigenic variation. Bethany J. Jenkins, Joanne M. Morrisey, Thomas M. Daly, Michael W. Mather, Akhil B. Vaidya, Lawrence W. Bergman 501 Drexel University College of Medicine, Philadelphia, PA, United States Coenzyme Q (CoQ, ubiquinone) is a central electron carrier in A SINGLE NUCLEOTIDE POLYMORPHISM IN THE PROMOTER mitochondrial respiration. CoQ is synthesized through multiple steps OF STROMAL CELL-DERIVED FACTOR (SDF)-1α (C-1002T) IS involving a number of different proteins. The prevailing view that the ASSOCIATED WITH PROTECTION AGAINST PLASMODIUM CoQ used in respiration exists as a free pool that diffuses throughout FALCIPARUM INFECTION IN KENYAN CHILDREN the mitochondrial inner membrane bilayer has recently been challenged.
    [Show full text]
  • PPCO Twist System
    PEER REVIEWED Challenges & New Developments in CANINE PYODERMA Disease Overview & Diagnosis Kimberly S. Coyner, DVM, Diplomate ACVD • Canine pyoderma is a bacterial skin dis- ease usually caused by Staphylococcus Cpseudintermedius (previously known as Staphylococcus intermedius).1 • S pseudintermedius is a gram-positive, coagulase-positive cocci bacteria, which is considered part of the normal canine mucosal flora and cultured from 37% to 41% of normal dogs.2,3 • Less common bacterial species found in canine pyodermas include S aure- us (4.7%–8.3% of cases, usually human origin) and S schleiferi (19%–28% of cases).4-6 DISEASE PROFILE Transmission The perineum and nasal mucosa are pri- mary colonization sites, and bacteria can be transferred to other body sites via lick- ing and grooming.2 • S pseudintermedius can be an oppor- tunistic pathogen and create infection in dogs with underlying conditions that compromise the normal skin barrier or immune function. This is the first article in a • Similar to S aureus, S pseudintermedius produces virulence 3-part series discussing the factors to enhance infection, such as coagulase, proteases, thermonuclease, and toxins (ie, haemolysins, exfoliative latest information available toxins, enterotoxins). It also has the ability to bind to fibrin- 1 regarding canine pyoderma. ogen, fibronectin, and cytokeratin, as well as form biofilms. Future articles will discuss Underlying Conditions Types of Conditions treatment as well as Chronic or recurrent canine pyoderma is usually associated methicillin-resistant infection. with an underlying cause; idiopathic pyoderma is rare. The most common underlying conditions include (Table 1, page 33):7 January/February 2012 Today’s Veterinary Practice 31 | CHALLENGES & NEW DEVELOPMENTS IN CANINE PYODERMA THE THREE Ms: MIC, MPC, & MSW Mean inhibitory concentration (MIC) is usually based on blood levels of an antibiotic, and is the minimal antibiotic concentration needed to inhibit bacterial growth.
    [Show full text]
  • Pyoderma Gangrenosum Or Necrotizing Fasciitis? a Diagnostic Conundrum
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector J Ped Surg Case Reports 1 (2013) 139e142 Contents lists available at SciVerse ScienceDirect Journal of Pediatric Surgery CASE REPORTS journal homepage: www.jpscasereports.com Pyoderma gangrenosum or necrotizing fasciitis? A diagnostic conundrum. Case report and literature review Michael W. Wangia a,*, Christina L. Mitchell a, Stanton K. Wesson a, Elisha Scott b, Fredereick L. Glavin c a Department of Dermatology, University of Florida College of Medicine, 4037 NW 86th Terrace, 4th Floor, Gainesville, FL 32606, USA b Department of Surgery, University of Florida College of Medicine, P.O. Box 100286, Gainesville, FL 32610, USA c Department of Pathology, University of Florida College of Medicine, 4800 SW 35 Dr., Gainesville, FL 32608, USA article info abstract Article history: Necrotizing fasciitis (NF) is a life-threatening, rare soft tissue infection characterized by rapidly spreading Received 6 April 2013 necrosis of the fascia and subcutaneous tissue, muscle, and overlying skin. Once suspected, immediate Accepted 7 May 2013 and extensive surgical debridement of necrotic tissues and appropriate systemic antibiotic coverage are necessary. On the contrary, pyoderma gangrenosum (PG) is an auto-inflammatory condition of the skin that has been associated with multiple factors including inflammatory bowel disease, arthritis, and Key words: myelodysplastic disorders. It is a non-infectious process requiring non-surgical management. Both Infectious fi fl conditions are rare in the pediatric population, and may present with signi cant ulceration and tissue In ammation fi Necrotizing fasciitis necrosis. Lack of diagnostic clinical, histopathologic, and laboratory features make identi cation of these Necrosis entities challenging.
    [Show full text]
  • Dermatological Indications of Disease - Part II This Patient on Dialysis Is Showing: A
    “Cutaneous Manifestations of Disease” ACOI - Las Vegas FR Darrow, DO, MACOI Burrell College of Osteopathic Medicine This 56 year old man has a history of headaches, jaw claudication and recent onset of blindness in his left eye. Sed rate is 110. He has: A. Ergot poisoning. B. Cholesterol emboli. C. Temporal arteritis. D. Scleroderma. E. Mucormycosis. Varicella associated. GCA complex = Cranial arteritis; Aortic arch syndrome; Fever/wasting syndrome (FUO); Polymyalgia rheumatica. This patient missed his vaccine due at age: A. 45 B. 50 C. 55 D. 60 E. 65 He must see a (an): A. neurologist. B. opthalmologist. C. cardiologist. D. gastroenterologist. E. surgeon. Medscape This 60 y/o male patient would most likely have which of the following as a pathogen? A. Pseudomonas B. Group B streptococcus* C. Listeria D. Pneumococcus E. Staphylococcus epidermidis This skin condition, erysipelas, may rarely lead to septicemia, thrombophlebitis, septic arthritis, osteomyelitis, and endocarditis. Involves the lymphatics with scarring and chronic lymphedema. *more likely pyogenes/beta hemolytic Streptococcus This patient is susceptible to: A. psoriasis. B. rheumatic fever. C. vasculitis. D. Celiac disease E. membranoproliferative glomerulonephritis. Also susceptible to PSGN and scarlet fever and reactive arthritis. Culture if MRSA suspected. This patient has antithyroid antibodies. This is: • A. alopecia areata. • B. psoriasis. • C. tinea. • D. lichen planus. • E. syphilis. Search for Hashimoto’s or Addison’s or other B8, Q2, Q3, DRB1, DR3, DR4, DR8 diseases. This patient who works in the electronics industry presents with paresthesias, abdominal pain, fingernail changes, and the below findings. He may well have poisoning from : A. lead. B.
    [Show full text]
  • Evidence-Based Management of Skin and Soft-Tissue Infections In
    VISIT US AT BOOTH # 203 AT THE ACEP PEDIATRIC ASSEMBLY IN NEW YORK, NY, MARCH 24-25, 2015 February 2015 Evidence-Based Management Volume 12, Number 2 Authors Of Skin And Soft-Tissue Jennifer E. Sanders, MD Pediatric Emergency Medicine Fellow, Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, Infections In Pediatric Patients New York, NY Sylvia E. Garcia, MD Assistant Professor of Pediatrics and Pediatric Emergency In The Emergency Department Medicine, Icahn School of Medicine at Mount Sinai, New York, NY Abstract Peer Reviewers Jeffrey Bullard-Berent, MD, FAAP, FACEP Skin and soft-tissue infections are among the most common condi- Health Sciences Professor, Emergency Medicine and Pediatrics, University of California – San Francisco, Benioff tions seen in children in the emergency department. Emergency de- Children’s Hospital, San Francisco, CA partment visits for these infections more than doubled between 1993 Carla Laos, MD, FAAP and 2005, and they currently account for approximately 2% of all Pediatric Emergency Medicine Physician, Dell Children’s Hospital, Austin, TX emergency department visits in the United States. This rapid increase CME Objectives in patient visits can be attributed largely to the pervasiveness of community-acquired methicillin-resistant Staphylococcus aureus. The Upon completion of this article, you should be able to: 1. Describe the pathophysiology of community-acquired emergence of this disease entity has created a great deal of controver- methicillin-resistant Staphylococcus aureus. sy regarding treatment regimens for skin and soft-tissue infections. 2. Differentiate the clinical presentation of common skin and soft-tissue infections. This issue of Pediatric Emergency Medicine Practice will focus on the 3.
    [Show full text]